EMEA (Europe, Middle East and Africa) Glucosylceramidase Market Report 2017

December 2017 | 102 pages | ID: E0A6B82EE6BEN
QYResearch

Abstracts

In this report, the EMEA Glucosylceramidase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Glucosylceramidase for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Glucosylceramidase market competition by top manufacturers/players, with Glucosylceramidase sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amicus Therapeutics, Inc.
• Bioorganic Research and Services S.A.
• greenovation Biotech GmbH
• JCR Pharmaceuticals Co., Ltd.
• Pharming Group N.V.
• Protalix BioTherapeutics, Inc.
• Shire Plc
• The International Biotechnology Center (IBC) Generium

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• AVRRD-02
• LTI-291
• NCGC-607
• Pcgin
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Genetic Disorders
• Gaucher Disease
• Parkinson's Disease
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Glucosylceramidase Market Report 2017

1 GLUCOSYLCERAMIDASE OVERVIEW

1.1 Product Overview and Scope of Glucosylceramidase
1.2 Classification of Glucosylceramidase
  1.2.1 EMEA Glucosylceramidase Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Glucosylceramidase Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 AVRRD-02
  1.2.4 LTI-291
  1.2.5 NCGC-607
  1.2.6 Pcgin
  1.2.7 Others
1.3 EMEA Glucosylceramidase Market by Application/End Users
  1.3.1 EMEA Glucosylceramidase Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Genetic Disorders
  1.3.3 Gaucher Disease
  1.3.4 Parkinson's Disease
  1.3.5 Others
1.4 EMEA Glucosylceramidase Market by Region
  1.4.1 EMEA Glucosylceramidase Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Glucosylceramidase (2012-2022)
  1.5.1 EMEA Glucosylceramidase Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Glucosylceramidase Revenue and Growth Rate (2012-2022)

2 EMEA GLUCOSYLCERAMIDASE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Glucosylceramidase Market Competition by Players/Manufacturers
  2.1.1 EMEA Glucosylceramidase Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Glucosylceramidase Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Glucosylceramidase Sale Price by Players (2012-2017)
2.2 EMEA Glucosylceramidase (Volume and Value) by Type/Product Category
  2.2.1 EMEA Glucosylceramidase Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Glucosylceramidase Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Glucosylceramidase Sale Price by Type (2012-2017)
2.3 EMEA Glucosylceramidase (Volume) by Application
2.4 EMEA Glucosylceramidase (Volume and Value) by Region
  2.4.1 EMEA Glucosylceramidase Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Glucosylceramidase Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Glucosylceramidase Sales Price by Region (2012-2017)

3 EUROPE GLUCOSYLCERAMIDASE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Glucosylceramidase Sales and Value (2012-2017)
  3.1.1 Europe Glucosylceramidase Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Glucosylceramidase Revenue and Growth Rate (2012-2017)
3.2 Europe Glucosylceramidase Sales and Market Share by Type
3.3 Europe Glucosylceramidase Sales and Market Share by Application
3.4 Europe Glucosylceramidase Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Glucosylceramidase Sales Volume by Countries (2012-2017)
  3.4.2 Europe Glucosylceramidase Revenue by Countries (2012-2017)
  3.4.3 Germany Glucosylceramidase Sales and Growth Rate (2012-2017)
  3.4.4 France Glucosylceramidase Sales and Growth Rate (2012-2017)
  3.4.5 UK Glucosylceramidase Sales and Growth Rate (2012-2017)
  3.4.6 Russia Glucosylceramidase Sales and Growth Rate (2012-2017)
  3.4.7 Italy Glucosylceramidase Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Glucosylceramidase Sales and Growth Rate (2012-2017)

4 MIDDLE EAST GLUCOSYLCERAMIDASE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Glucosylceramidase Sales and Value (2012-2017)
  4.1.1 Middle East Glucosylceramidase Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Glucosylceramidase Revenue and Growth Rate (2012-2017)
4.2 Middle East Glucosylceramidase Sales and Market Share by Type
4.3 Middle East Glucosylceramidase Sales and Market Share by Application
4.4 Middle East Glucosylceramidase Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Glucosylceramidase Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Glucosylceramidase Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Glucosylceramidase Sales and Growth Rate (2012-2017)
  4.4.4 Israel Glucosylceramidase Sales and Growth Rate (2012-2017)
  4.4.5 UAE Glucosylceramidase Sales and Growth Rate (2012-2017)
  4.4.6 Iran Glucosylceramidase Sales and Growth Rate (2012-2017)

5 AFRICA GLUCOSYLCERAMIDASE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Glucosylceramidase Sales and Value (2012-2017)
  5.1.1 Africa Glucosylceramidase Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Glucosylceramidase Revenue and Growth Rate (2012-2017)
5.2 Africa Glucosylceramidase Sales and Market Share by Type
5.3 Africa Glucosylceramidase Sales and Market Share by Application
5.4 Africa Glucosylceramidase Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Glucosylceramidase Sales Volume by Countries (2012-2017)
  5.4.2 Africa Glucosylceramidase Revenue by Countries (2012-2017)
  5.4.3 South Africa Glucosylceramidase Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Glucosylceramidase Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Glucosylceramidase Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Glucosylceramidase Sales and Growth Rate (2012-2017)

6 EMEA GLUCOSYLCERAMIDASE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Amicus Therapeutics, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Glucosylceramidase Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amicus Therapeutics, Inc. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bioorganic Research and Services S.A.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Glucosylceramidase Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bioorganic Research and Services S.A. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 greenovation Biotech GmbH
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Glucosylceramidase Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 greenovation Biotech GmbH Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 JCR Pharmaceuticals Co., Ltd.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Glucosylceramidase Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pharming Group N.V.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Glucosylceramidase Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pharming Group N.V. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Protalix BioTherapeutics, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Glucosylceramidase Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Protalix BioTherapeutics, Inc. Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Shire Plc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Glucosylceramidase Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Shire Plc Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 The International Biotechnology Center (IBC) Generium
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Glucosylceramidase Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 GLUCOSYLCERAMIDASE MANUFACTURING COST ANALYSIS

7.1 Glucosylceramidase Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Glucosylceramidase

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Glucosylceramidase Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Glucosylceramidase Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GLUCOSYLCERAMIDASE MARKET FORECAST (2017-2022)

11.1 EMEA Glucosylceramidase Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Glucosylceramidase Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Glucosylceramidase Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Glucosylceramidase Price and Trend Forecast (2017-2022)
11.2 EMEA Glucosylceramidase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Glucosylceramidase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Glucosylceramidase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Glucosylceramidase Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Glucosylceramidase Sales Forecast by Type (2017-2022)
11.7 EMEA Glucosylceramidase Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Glucosylceramidase
Figure EMEA Glucosylceramidase Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Glucosylceramidase Sales Volume Market Share by Type (Product Category) in 2016
Figure AVRRD-02 Product Picture
Figure LTI-291 Product Picture
Figure NCGC-607 Product Picture
Figure Pcgin Product Picture
Figure Others Product Picture
Figure EMEA Glucosylceramidase Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Glucosylceramidase by Application in 2016
Figure Genetic Disorders Examples
Table Key Downstream Customer in Genetic Disorders
Figure Gaucher Disease Examples
Table Key Downstream Customer in Gaucher Disease
Figure Parkinson's Disease Examples
Table Key Downstream Customer in Parkinson's Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Glucosylceramidase Market Size (Million USD) by Region (2012-2022)
Figure Europe Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Glucosylceramidase Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Glucosylceramidase Revenue (Million USD) Status and Forecast by Countries
Figure Africa Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Glucosylceramidase Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Glucosylceramidase Sales Volume and Growth Rate (2012-2022)
Figure EMEA Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Glucosylceramidase Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Glucosylceramidase Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Glucosylceramidase Sales Share by Players (2012-2017)
Figure 2016 Glucosylceramidase Sales Share by Players
Figure 2017 Glucosylceramidase Sales Share by Players
Figure EMEA Glucosylceramidase Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Glucosylceramidase Revenue (Million USD) by Players (2012-2017)
Table EMEA Glucosylceramidase Revenue Share by Players (2012-2017)
Table 2016 EMEA Glucosylceramidase Revenue Share by Players
Table 2017 EMEA Glucosylceramidase Revenue Share by Players
Table EMEA Glucosylceramidase Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Glucosylceramidase Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Glucosylceramidase Sales Share by Type (2012-2017)
Figure Sales Market Share of Glucosylceramidase by Type (2012-2017)
Figure EMEA Glucosylceramidase Sales Market Share by Type (2012-2017)
Table EMEA Glucosylceramidase Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Glucosylceramidase Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Glucosylceramidase by Type in 2016
Table EMEA Glucosylceramidase Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Glucosylceramidase Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Glucosylceramidase Sales Share by Application (2012-2017)
Figure Sales Market Share of Glucosylceramidase by Application (2012-2017)
Figure EMEA Glucosylceramidase Sales Market Share by Application in 2016
Table EMEA Glucosylceramidase Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Glucosylceramidase Sales Share by Region (2012-2017)
Figure Sales Market Share of Glucosylceramidase by Region (2012-2017)
Figure EMEA Glucosylceramidase Sales Market Share in 2016
Table EMEA Glucosylceramidase Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Glucosylceramidase Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Glucosylceramidase by Region (2012-2017)
Figure EMEA Glucosylceramidase Revenue Market Share Regions in 2016
Table EMEA Glucosylceramidase Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Glucosylceramidase Revenue and Growth Rate (2012-2017)
Table Europe Glucosylceramidase Sales (K Pcs) by Type (2012-2017)
Table Europe Glucosylceramidase Market Share by Type (2012-2017)
Figure Europe Glucosylceramidase Market Share by Type in 2016
Table Europe Glucosylceramidase Sales (K Pcs) by Application (2012-2017)
Table Europe Glucosylceramidase Market Share by Application (2012-2017)
Figure Europe Glucosylceramidase Market Share by Application in 2016
Table Europe Glucosylceramidase Sales (K Pcs) by Countries (2012-2017)
Table Europe Glucosylceramidase Sales Market Share by Countries (2012-2017)
Figure Europe Glucosylceramidase Sales Market Share by Countries (2012-2017)
Figure Europe Glucosylceramidase Sales Market Share by Countries in 2016
Table Europe Glucosylceramidase Revenue (Million USD) by Countries (2012-2017)
Table Europe Glucosylceramidase Revenue Market Share by Countries (2012-2017)
Figure Europe Glucosylceramidase Revenue Market Share by Countries (2012-2017)
Figure Europe Glucosylceramidase Revenue Market Share by Countries in 2016
Figure Germany Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Glucosylceramidase Sales (K Pcs) by Type (2012-2017)
Table Middle East Glucosylceramidase Market Share by Type (2012-2017)
Figure Middle East Glucosylceramidase Market Share by Type (2012-2017)
Table Middle East Glucosylceramidase Sales (K Pcs) by Applications (2012-2017)
Table Middle East Glucosylceramidase Market Share by Applications (2012-2017)
Figure Middle East Glucosylceramidase Sales Market Share by Application in 2016
Table Middle East Glucosylceramidase Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Glucosylceramidase Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Glucosylceramidase Sales Volume Market Share by Countries in 2016
Table Middle East Glucosylceramidase Revenue (Million USD) by Countries (2012-2017)
Table Middle East Glucosylceramidase Revenue Market Share by Countries (2012-2017)
Figure Middle East Glucosylceramidase Revenue Market Share by Countries (2012-2017)
Figure Middle East Glucosylceramidase Revenue Market Share by Countries in 2016
Figure Saudi Arabia Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Glucosylceramidase Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Glucosylceramidase Sales (K Pcs) by Type (2012-2017)
Table Africa Glucosylceramidase Sales Market Share by Type (2012-2017)
Figure Africa Glucosylceramidase Sales Market Share by Type (2012-2017)
Figure Africa Glucosylceramidase Sales Market Share by Type in 2016
Table Africa Glucosylceramidase Sales (K Pcs) by Application (2012-2017)
Table Africa Glucosylceramidase Sales Market Share by Application (2012-2017)
Figure Africa Glucosylceramidase Sales Market Share by Application (2012-2017)
Table Africa Glucosylceramidase Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Glucosylceramidase Sales Market Share by Countries (2012-2017)
Figure Africa Glucosylceramidase Sales Market Share by Countries (2012-2017)
Figure Africa Glucosylceramidase Sales Market Share by Countries in 2016
Table Africa Glucosylceramidase Revenue (Million USD) by Countries (2012-2017)
Table Africa Glucosylceramidase Revenue Market Share by Countries (2012-2017)
Figure Africa Glucosylceramidase Revenue Market Share by Countries (2012-2017)
Figure Africa Glucosylceramidase Revenue Market Share by Countries in 2016
Figure South Africa Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Table Amicus Therapeutics, Inc. Glucosylceramidase Basic Information List
Table Amicus Therapeutics, Inc. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amicus Therapeutics, Inc. Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amicus Therapeutics, Inc. Glucosylceramidase Sales Market Share in EMEA (2012-2017)
Figure Amicus Therapeutics, Inc. Glucosylceramidase Revenue Market Share in EMEA (2012-2017)
Table Bioorganic Research and Services S.A. Glucosylceramidase Basic Information List
Table Bioorganic Research and Services S.A. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bioorganic Research and Services S.A. Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bioorganic Research and Services S.A. Glucosylceramidase Sales Market Share in EMEA (2012-2017)
Figure Bioorganic Research and Services S.A. Glucosylceramidase Revenue Market Share in EMEA (2012-2017)
Table greenovation Biotech GmbH Glucosylceramidase Basic Information List
Table greenovation Biotech GmbH Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure greenovation Biotech GmbH Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure greenovation Biotech GmbH Glucosylceramidase Sales Market Share in EMEA (2012-2017)
Figure greenovation Biotech GmbH Glucosylceramidase Revenue Market Share in EMEA (2012-2017)
Table JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Basic Information List
Table JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Sales Market Share in EMEA (2012-2017)
Figure JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Revenue Market Share in EMEA (2012-2017)
Table Pharming Group N.V. Glucosylceramidase Basic Information List
Table Pharming Group N.V. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pharming Group N.V. Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pharming Group N.V. Glucosylceramidase Sales Market Share in EMEA (2012-2017)
Figure Pharming Group N.V. Glucosylceramidase Revenue Market Share in EMEA (2012-2017)
Table Protalix BioTherapeutics, Inc. Glucosylceramidase Basic Information List
Table Protalix BioTherapeutics, Inc. Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Protalix BioTherapeutics, Inc. Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Protalix BioTherapeutics, Inc. Glucosylceramidase Sales Market Share in EMEA (2012-2017)
Figure Protalix BioTherapeutics, Inc. Glucosylceramidase Revenue Market Share in EMEA (2012-2017)
Table Shire Plc Glucosylceramidase Basic Information List
Table Shire Plc Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shire Plc Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure Shire Plc Glucosylceramidase Sales Market Share in EMEA (2012-2017)
Figure Shire Plc Glucosylceramidase Revenue Market Share in EMEA (2012-2017)
Table The International Biotechnology Center (IBC) Generium Glucosylceramidase Basic Information List
Table The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales (K Pcs) and Growth Rate (2012-2017)
Figure The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales Market Share in EMEA (2012-2017)
Figure The International Biotechnology Center (IBC) Generium Glucosylceramidase Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucosylceramidase
Figure Manufacturing Process Analysis of Glucosylceramidase
Figure Glucosylceramidase Industrial Chain Analysis
Table Raw Materials Sources of Glucosylceramidase Major Manufacturers in 2016
Table Major Buyers of Glucosylceramidase
Table Distributors/Traders List
Figure EMEA Glucosylceramidase Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Glucosylceramidase Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Glucosylceramidase Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Glucosylceramidase Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Glucosylceramidase Sales Market Share Forecast by Region (2017-2022)
Table EMEA Glucosylceramidase Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Glucosylceramidase Revenue Market Share Forecast by Region (2017-2022)
Table Europe Glucosylceramidase Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Glucosylceramidase Sales Market Share Forecast by Countries (2017-2022)
Table Europe Glucosylceramidase Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Glucosylceramidase Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Glucosylceramidase Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Glucosylceramidase Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Glucosylceramidase Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Glucosylceramidase Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Glucosylceramidase Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Glucosylceramidase Sales Market Share Forecast by Countries (2017-2022)
Table Africa Glucosylceramidase Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Glucosylceramidase Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Glucosylceramidase Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Glucosylceramidase Sales Market Share Forecast by Type (2017-2022)
Table EMEA Glucosylceramidase Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Glucosylceramidase Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources